Results 221 to 230 of about 3,445,878 (379)
Molecular Oncology, EarlyView.This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain +3 more
wiley +1 more source
RUDN Journal of Ecology and Life Safety, 2009 Biologically active dietary supplement «Transfer-Factor», produced by «4 Life Research Co» (the USA) from cow beestings reestablishes the potential of cellular growth lowered within the processes of aging what is estimated on the pharmacologically ...
V I Dontsov +5 more
doaj
Antigenic Specificities of the Cellular Immune Response of C57BL/6 Mice to the Moloney Leukemia/Sarcoma Virus Complex [PDF]
, 1979 Luis Enjuanes +2 more
openalex +1 more source
Interplay of integrins and selectins in metastasis
Molecular Oncology, EarlyView.Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva +2 more
wiley +1 more source
Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis [PDF]
, 1977 Dexter H. Howard, V Otto
openalex +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Molecular Oncology, EarlyView.Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson +11 more
wiley +1 more source